
Shares of toothpaste maker Colgate-Palmolive CL.N rise nearly 1% to $77.85 premarket
Piper Sandler upgrades stock rating to "overweight" from 'neutral'; raises PT to $88 from $82, representing ~14% upside to stock's last close
Brokerage expects CL to have experienced continued softness in both revenue and earnings momentum in 4Q25, driven primarily by weaker trends in the U.S.
However, brokerage says growth could reaccelerate in 2026, supported by early signs of improvement in emerging markets
Twenty-two analysts rate the stock "buy" on average; median PT is $88 -- data compiled by LSEG
As of last close, CL is down ~12% in the past 12 months